The Top 40 Under 40 Power List 2026 is Live!
September 21, 2026
Meet the rising stars set to shape the future of analytical science
1 min read
False
September
GCxGC Detective Stories: The Case of the Disappearing Diesel
September 16, 2026
How GC×GC helped to reopen the “Silent Fall” oil-spill investigation and reveal what happened to diesel buried beneath Cape Cod’s salt marsh
5 min read
Mass Spec Roundup: Fragment Ions and Fossil Fragments
September 16, 2026
This week’s stories span AI-assisted metabolite annotation, spatial drug-target engagement, Denisovan proteomics, and machine-learning elemental detection.
5 min read
Spectroscopy Roundup: Sorting, Screening, and Sensing
September 15, 2026
Spectroscopy sorts cells, distinguishes fruit-surface contaminants, guides recyclable packaging design, and screens toys for potentially toxic elements.
5 min read
A Finer Approach to Native MS
September 14, 2026
Emily Byrd discusses the cross-platform potential of nanopipette emitters for analyzing proteins directly in challenging biochemical buffers
4 min read
Precision Medicine Starts with the Sample
September 9, 2026
Why sample integrity, robust workflows, and operational rigor are as important as analytical innovation in translating complex biological data into better patient care
7 min read
Mass Spec Roundup: Profiling Proteins in Individual Bacteria
September 9, 2026
New approaches push proteomics to single bacteria, infer residue-level HX energetics, streamline glycopeptide prep, and extend LC–IRMS to halogenated pollutants
5 min read
Misfolded in Plain Sight
September 8, 2026
Ubiquitin mass spectrometry and molecular simulations suggest near-native misfolded proteins can evade cellular quality control
2 min read
GCxGC Detective Stories: The Smell of Adventure
September 7, 2026
How a career spanning three continents prepared Meriem Gaida to bring GC×GC into fragrance safety and quality analysis
6 min read
Can Tumor Organoids Make Drug Discovery More Predictive?
September 3, 2026
How patient-derived tumor organoids, high-content screening, and advanced analytical readouts could provide more predictive models for cancer drug discovery
8 min read
